18. O'Brien SM, Lamanna N, Kipps TJ, Flinn I, Zelenetz AD, Burger JA, et al. A phase 2 study of
idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia. Blood.
2015;126(25):2686-94.
19. Dewan AK, Gupta S, Bach DQ, ety al. Psoriasiform eruptions secondary to Phosphoinositide 3-kinase
inhibition. JAAD Case Rep. 2019 Apr 20;5(5):401-405.
20. Dewan AK, Sowerby L, Jadeja S, et al. Pityriasis rubra pilaris-like erythroderma secondary to
phosphoinositide 3-kinase inhibition. Clin Exp Dermatol. 2018 Dec;43(8):890-894.
